Jean Jacques Bienaime

Director at Immunome · 14 reported transactions in 4 companies · latest trade Aug 14, 2026

Their record

Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.

Typical move +100.1%, S&P 500 +10.6% over the same days.

3 more are too recent to measure.

Their trades


Ascendis PharmaASND	Bought $222.2K · 900 shares	Aug 14, 2026	S&P 500 −1.4%thru Oct 26
Ascendis PharmaASND	Bought $270.4K · 1,100 shares	Aug 14, 2026	S&P 500 −1.4%thru Oct 26
Keros TherapeuticsKROS	Bought $10.6K · 1,000 shares	Jul 15, 2026	S&P 500 +0.1%thru Oct 30
ImmunomeIMNM	Bought $19.3K · 1,000 shares	Jun 5, 2026	S&P 500 +2.5%thru Oct 30
ImmunomeIMNM	Bought $68.1K · 3,500 shares	Jun 5, 2026	S&P 500 +2.5%thru Oct 30
ImmunomeIMNM	Bought $116.9K · 6,000 shares	Jun 5, 2026	S&P 500 +2.5%thru Oct 30
ImmunomeIMNM	Sold $194.1K · 10,000 shares	Jun 5, 2026	S&P 500 +2.5%thru Oct 30
ImmunomeIMNM	Sold $9.7K · 500 shares	Jun 5, 2026	S&P 500 +2.5%thru Oct 30
Keros TherapeuticsKROS	Bought $10.6K · 1,000 shares	May 15, 2026	S&P 500 +2.2%thru Oct 30

BoughtAscendis Pharma

Aug 14, 2026 · ASND

$222.2K

S&P 500 −1.4%thru Oct 26

BoughtAscendis Pharma

Aug 14, 2026 · ASND

$270.4K

S&P 500 −1.4%thru Oct 26

BoughtKeros Therapeutics

Jul 15, 2026 · KROS

$10.6K

S&P 500 +0.1%thru Oct 30

Jun 5, 2026 · IMNM

$19.3K

S&P 500 +2.5%thru Oct 30

Jun 5, 2026 · IMNM

$68.1K

S&P 500 +2.5%thru Oct 30

Jun 5, 2026 · IMNM

$116.9K

S&P 500 +2.5%thru Oct 30

Jun 5, 2026 · IMNM

$194.1K

S&P 500 +2.5%thru Oct 30

Jun 5, 2026 · IMNM

$9.7K

S&P 500 +2.5%thru Oct 30

BoughtKeros Therapeutics

May 15, 2026 · KROS

$10.6K

S&P 500 +2.2%thru Oct 30

Newest 10 of 14 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.